Literature DB >> 23224227

All-cause and cause-specific mortality after hip fracture among Chinese women and men: the Singapore Chinese Health Study.

G C-H Koh1, B C Tai, L-W Ang, D Heng, J-M Yuan, W-P Koh.   

Abstract

UNLABELLED: All-cause mortality risk persisted for 5 years after hip fractures in both men and women. There may be gender-specific differences in effect and duration of excess risk for cause-specific mortality after hip fracture.
INTRODUCTION: To determine all-cause and cause-specific mortality risk in the first 5 years after hip fracture in an Asian Chinese population.
METHODS: The Singapore Chinese Health Study is a population-based cohort of 63,257 middle-aged and elderly Chinese men and women in Singapore recruited between 1993 and 1998. This cohort was followed up for hip fracture and death via linkage with nationwide hospital discharge database and death registry. As of 31 December 2008, we identified 1,166 hip fracture cases and matched five non-fracture cohort subjects by age and gender for each fracture case. Cox proportional hazards and competing risks regression models with hip fracture as a time-dependent covariate were used to determine all-cause and cause-specific mortality risk, respectively.
RESULTS: Increase in all-cause mortality risk persisted till 5 years after hip fracture (adjusted hazard ratio, aHR = 1.58 [95 % CI, 1.35-1.86] for females and aHR = 1.64 [95 % CI, 1.30-2.06] for males). Men had higher mortality risk after hip fracture than women for deaths from stroke and cancer up to 1 year post-fracture but women with hip fracture had higher coronary artery mortality risk than men for 5 years post-fracture. Men had higher risk of death from pneumonia while women had increased risk of death from urinary tract infections. There was no difference in mortality risk by types of hip fracture surgery.
CONCLUSIONS: All-cause mortality risk persisted for 5 years after hip fractures in men and women. There are gender-specific differences in effect size and duration of excess mortality risk from hip fractures between specific causes of death.

Entities:  

Mesh:

Year:  2012        PMID: 23224227      PMCID: PMC9244854          DOI: 10.1007/s00198-012-2183-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  22 in total

1.  Rate of bone loss is associated with mortality in older women: a prospective study.

Authors:  D M Kado; W S Browner; T Blackwell; R Gore; S R Cummings
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  Functional outcome after hip fracture in Japan.

Authors:  S Kitamura; Y Hasegawa; S Suzuki; R Sasaki; H Iwata; H Wingstrand; K G Thorngren
Journal:  Clin Orthop Relat Res       Date:  1998-03       Impact factor: 4.176

3.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

Authors:  T B Harris; L Ferrucci; R P Tracy; M C Corti; S Wacholder; W H Ettinger; H Heimovitz; H J Cohen; R Wallace
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

4.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

Review 5.  The pathophysiologic roles of interleukin-6 in human disease.

Authors:  D A Papanicolaou; R L Wilder; S C Manolagas; G P Chrousos
Journal:  Ann Intern Med       Date:  1998-01-15       Impact factor: 25.391

6.  Treatment and survival among elderly Americans with hip fractures: a population-based study.

Authors:  G L Lu-Yao; J A Baron; J A Barrett; E S Fisher
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

Review 7.  Interleukin-6: a cytokine for gerontologists.

Authors:  W B Ershler
Journal:  J Am Geriatr Soc       Date:  1993-02       Impact factor: 5.562

Review 8.  Mortality following hip fracture: trends and geographical variations over the last 40 years.

Authors:  S Haleem; L Lutchman; R Mayahi; J E Grice; M J Parker
Journal:  Injury       Date:  2008-07-24       Impact factor: 2.586

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Analysis and design of randomised clinical trials involving competing risks endpoints.

Authors:  Bee-Choo Tai; Joseph Wee; David Machin
Journal:  Trials       Date:  2011-05-19       Impact factor: 2.279

View more
  16 in total

1.  Alcohol consumption and hip fracture risk.

Authors:  X Zhang; Z Yu; M Yu; X Qu
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

2.  Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.

Authors:  Ji Hyun Lee; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

3.  Predictors of excess mortality after fracture: a population-based cohort study.

Authors:  L Joseph Melton; Elizabeth J Atkinson; Jennifer L St Sauver; Sara J Achenbach; Terry M Therneau; Walter A Rocca; Shreyasee Amin
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

4.  Author's reply.

Authors:  Eileen Tay
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

5.  A survey of outcomes and management of patients post fragility fractures in China.

Authors:  O Wang; Y Hu; S Gong; Q Xue; Z Deng; L Wang; H Liu; H Tang; X Guo; J Chen; X Jia; Y Xu; L Lan; C Lei; H Dong; G Yuan; Q Fu; Y Wei; W Xia; L Xu
Journal:  Osteoporos Int       Date:  2015-05-13       Impact factor: 4.507

6.  Hip fracture, mortality risk, and cause of death over two decades.

Authors:  M von Friesendorff; F E McGuigan; A Wizert; C Rogmark; A H Holmberg; A D Woolf; K Akesson
Journal:  Osteoporos Int       Date:  2016-05-12       Impact factor: 4.507

Review 7.  Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention.

Authors:  Haiyang Wu; Zaijie Sun; Linjian Tong; Yulin Wang; Hua Yan; Zhiming Sun
Journal:  Arch Osteoporos       Date:  2021-10-11       Impact factor: 2.617

8.  Association between loop diuretic use and fracture risk.

Authors:  F Xiao; X Qu; Z Zhai; C Jiang; H Li; X Liu; Z Ouyang; D Gu
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

9.  Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.

Authors:  M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; Y Sato; J S Moon; A Harano; K Hazaki; E Kajita; M Hamada; K Arai; K Tomioka; N Okamoto; N Kurumatani
Journal:  Osteoporos Int       Date:  2016-10-18       Impact factor: 4.507

Review 10.  Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Nicola Veronese; Brendon Stubbs; Gaetano Crepaldi; Marco Solmi; Cyrus Cooper; Nicolas Cw Harvey; Jean-Yves Reginster; Renè Rizzoli; Roberto Civitelli; Patricia Schofield; Stefania Maggi; Sarah E Lamb
Journal:  J Bone Miner Res       Date:  2017-03-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.